Telesis Bio's market cap is currently $621.54K. The company's EPS TTM is $-28.186; its P/E ratio is ―; Telesis Bio is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 27.51M	$ 27.43M	$ 11.04M	$ 6.58M	$ 4.80M
Gross Profit	$ 16.95M	$ 15.60M	$ 4.30M	$ 3.63M	$ -4.08M
Operating Income	$ -46.54M	$ -46.48M	$ -35.37M	$ -16.36M	$ -6.98M
EBITDA	$ -40.49M	$ -43.62M	$ -36.00M	$ -15.49M	$ -6.12M
Net Income	$ -47.72M	$ -48.47M	$ -38.96M	$ -18.01M	$ -8.30M
Balance Sheet
Cash & Short-Term Investments	$ 19.16M	$ 43.75M	$ 82.81M	$ 13.46M	$ 29.14M
Total Assets	$ 70.41M	$ 81.36M	$ 116.26M	$ 26.86M	$ 38.76M
Total Debt	$ 34.38M	$ 21.43M	$ 17.32M	$ 8.33M	$ 4.77M
Net Debt	$ 32.81M	$ -8.99M	$ -65.48M	$ -5.14M	$ -24.38M
Total Liabilities	$ 40.87M	$ 34.80M	$ 25.47M	$ 52.32M	$ 46.26M
Stockholders' Equity	$ 29.54M	$ -113.74M	$ 90.78M	$ -25.46M	$ -7.50M
Cash Flow
Free Cash Flow	$ -36.65M	$ -43.18M	$ -38.55M	$ -15.59M	$ -6.47M
Operating Cash Flow	$ -34.67M	$ -38.72M	$ -36.70M	$ -15.38M	$ -6.39M
Investing Cash Flow	$ -5.74M	$ -18.01M	$ -15.04M	$ -204.00K	$ -79.00K
Financing Cash Flow	$ 11.56M	$ 4.51M	$ 121.08M	$ -96.00K	$ 35.11M

Currency in USD

Telesis Bio Earnings and Revenue History

Income Statement >

Telesis Bio Debt to Assets

Balance Sheet >

Telesis Bio Cash Flow

Cash Flow >

Telesis Bio Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing